Capreomycin and Parenteral Aminoglycosides

"Capreomycin and Parenteral Aminoglycosides" is an administrative and clinical grouping rather than a distinct, singular pharmacological class It encompasses parenterally administered second-line antituberculosis agents consisting of the cyclic peptide capreomycin alongside injectable aminoglycosides such as amikacin, kanamycin, and streptomycin Historically essential for multidrug-resistant tuberculosis and select severe mycobacterial infections, their clinical utility has significantly diminis...

"Capreomycin and Parenteral Aminoglycosides" is an administrative and clinical grouping rather than a distinct, singular pharmacological class It encompasses parenterally administered second-line antituberculosis agents consisting of the cyclic peptide capreomycin alongside injectable aminoglycosides such as amikacin, kanamycin, and streptomycin

It encompasses parenterally administered second-line antituberculosis agents consisting of the cyclic peptide capreomycin alongside injectable aminoglycosides such as amikacin, kanamycin, and streptomycin These bactericidal or bacteriostatic agents work by binding to bacterial ribosomal subunits to disrupt protein synthesis and induce mistranslation

These bactericidal or bacteriostatic agents work by binding to bacterial ribosomal subunits to disrupt protein synthesis and induce mistranslation

Historically essential for multidrug-resistant tuberculosis and select severe mycobacterial infections, their clinical utility has significantly diminished in modern guidelines due to severe nephrotoxicity, ototoxicity, and the advent of safer, all-oral antituberculosis regimens

Historically essential for multidrug-resistant tuberculosis and select severe mycobacterial infections, their clinical utility has significantly diminished in modern guidelines due to severe nephrotoxicity, ototoxicity, and the advent of safer, all-oral antituberculosis regimens